FDA Urges Bayer to Add Warnings on Yaz Label
The United States' Food and Drug Administration's advisory panel announced in December 2011 that they had come to the conclusion that warning labels on the popular birth control medication Yaz were not sufficient enough to adequately inform patients of the risks associated with the medication.... Read More